NovAccess Global Inc.
NovAccess Global Inc.
Your view on XSNX
Overview
What the company does, where it operates, and who runs it.
About NovAccess Global Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Dwain K. Morris-Irvin
- Headquarters
- 8834 Mayfield Road, Chesterland, OH, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Dwain K. Morris-Irvin
- Headquarters
- 8834 Mayfield Road, Chesterland, OH, US
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.